The hiring of a professional proxy solicitor at a $33M market cap company signals management is concerned about vote counts—likely due to activist pressure or low retail participation. Monitor for any dissident proxy materials (DFAN14A) ahead of the June 11 meeting; a contested vote could drive volatility.
Price Chart
Executive Summary
Dare Bioscience filed a DEFA14A supplement to its proxy statement, disclosing the engagement of Okapi Partners LLC as an independent proxy solicitor for the June 11, 2026 annual meeting. The $15,000 fee plus expenses is a routine administrative step, but the engagement of a professional solicitor at a micro-cap biotech suggests management anticipates a contested vote or low retail turnout, warranting attention.
Key Financial Metrics
Key Facts
- Engaged Okapi Partners LLC as proxy solicitor for $15,000 fee plus expenses
- Annual meeting scheduled for June 11, 2026
- Supplement filed June 1, 2026, supplementing April 28, 2026 proxy statement
- Management paying entire cost of solicitation; directors/employees may solicit without extra compensation
Financial Impact
$15,000 fee plus additional expenses for proxy solicitation services
Risk Factors
- Potential activist campaign or dissident slate could emerge before the meeting
- Low institutional ownership may amplify retail vote uncertainty
- Proxy fight costs could strain cash reserves for a micro-cap biotech
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001493152-26-026666 |
| Document: 0001493152-26-026666-index-headers.html | 0001493152-26-026666 |
| Document: 0001493152-26-026666-index.html | 0001493152-26-026666 |
| Document: 0001493152-26-026666.txt | 0001493152-26-026666 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 6, 2026 19d ago | DEF 14A | $0.7900 $0.7720 | ▲ +2.28% | ▲ +1.86% | $0.6467 (+18.14%) |
Oct 1, 2026 25d ago | 8-K | $0.8510 $0.8428 | ▼ −0.96% | ▼ −1.70% | $0.6467 (−24.01%) |
Sep 9, 2026 6w ago | 8-K | $0.7166 $0.7051 | ▼ −1.60% | ▼ −1.01% | $0.6467 (−9.75%) |
Sep 4, 2026 7w ago | EFFECT | $0.7210 $0.7130 | ▲ +1.11% | ▲ +0.56% | $0.6467 (+10.31%) |
Aug 17, 2026 10w ago | 8-K | $0.8102 $0.7682 | ▲ +5.18% | ▲ +4.51% | $0.6467 (+20.18%) |
Aug 17, 2026 10w ago | 424B5 | $0.8102 $0.7682 | ▲ +5.18% | ▲ +4.51% | $0.6467 (+20.18%) |
Aug 13, 2026 10w ago | 8-K | $0.9300 $0.8102 | ▼ −12.88% | ▼ −12.41% | $0.6467 (−30.46%) |
Aug 6, 2026 11w ago | Press Release | $1.33 $1.40 | ▲ +5.26% | ▲ +4.65% | $0.6467 (−51.38%) |
Jul 24, 2026 13w ago | 8-K | $1.28 $1.32 | ▲ +3.13% | ▲ +3.10% | $0.6467 (−49.48%) |
Jul 13, 2026 15w ago | 8-K | $2.09 $2.07 | ▼ −0.96% | ▼ −1.31% | $0.6467 (−69.06%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers